Table 1.
Effect of prostate cancer on anthropometric data. Values are expressed as mean ± standard deviation.
| Cont1 (n = 8) | PCa1 (n = 10) | Cont2 (n = 10) | PCa2 (n = 14) | |
|---|---|---|---|---|
| Body weight (g) | 471.7 ± 27.8 | 408.5 ± 23.3 ** | 541.8 ± 44.9 *** | 494.6 ± 35.4 ####,+ |
| Body weight-to-tibial length ratio (g·cm−1) |
53.0 ± 3.3 | 46.8 ± 2.5 | 119.4 ± 9.5 **** | 112.5 ± 8.1 #### |
| Prostate weight (g) |
2.7 ± 0.3 | 4.4 ± 0.4 **** | 2.9 ± 0.3 | 4.8 ± 0.7 ++++ |
| Prostate-to- tibial length ratio (g·cm−1) |
0.3 ± 0.1 | 0.5 ± 0.1 **** | 0.6 ± 0.1 **** | 1.0 ± 0.1 ####,++++ |
| Gastrocnemius muscle weight (mg) | 4.7 ± 0.2 | 4.1 ± 0.4 ** | 4.4 ± 0.3 | 4.5 ± 0.3 |
| Gastrocnemius-to-body weight ratio (mg·g−1) | 1.0 ± 0.1 | 1.0 ± 0.1 | 0.8 ± 0.1 *** | 0.9 ± 0.1 ## |
| Adipose tissue weight (g) | 3.8 ± 0.6 | 3.4 ± 0.4 | 12.8 ± 3.5 **** | 9.8 ± 1.9 ###,+ |
| Adipose tissue-to-body weight ratio (mg·g−1) | 0.8 ± 0.2 | 0.8 ± 0.1 | 2.3 ± 0.5 **** | 2.0 ± 0.4 #### |
| Retroperitoneal adipose tissue weight (g) | 2.8 ± 0.4 | 2.7 ± 0.3 | 0.9 ± 0.4 **** | 0.8 ± 0.4 #### |
| Retroperitoneal adipose tissue-to-body weight ratio (mg·g−1) | 0.6 ± 0.1 | 0.6 ± 0.1 | 0.2 ± 0.1 **** | 0.1 ± 0.1 #### |
| Mesenteric adipose tissue weight (g) | 1.0 ± 0.2 | 0.7 ± 0.1 | 11.8 ± 3.3 **** | 9.1 ± 1.8 ####,+ |
| Mesenteric adipose tissue-to-body weight ratio (mg·g−1) | 0.2 ± 0.1 | 0.2 ± 0.1 | 2.2 ± 0.5 **** | 1.8 ± 0.3 #### |
** p < 0.01 vs. Cont1, *** p < 0.001 vs. Cont1, **** p < 0.0001 vs. Cont1, ## p < 0.01 vs. PCa1, ### p < 0.001 vs. PCa1, #### p < 0.0001 vs. PCa1, + p < 0.05 vs. Cont2, ++++ p < 0.0001 vs. Cont2.